sodium (2S,2'S,5R,5'R,6R,6'R)-6,6'-((1E,1'E)-(6,6',7,7'-tetrahydroxy-5,5'-diisopropyl-3,3'-dimethyl-1,1',4,4'-tetraoxo-1,1',4,4'-tetrahydro-2,2'-binaphthyl-8,8'-diyl)bis(methan-1-yl-1-ylidene)bis(azan-1-yl-1-ylidene))bis(3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate)

ID: ALA1215012

Chembl Id: CHEMBL1215012

Max Phase: Preclinical

Molecular Formula: C46H44N4Na2O14S2

Molecular Weight: 943.02

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1=C(C2=C(C)C(=O)c3c(c(/C=N/[C@@H]4C(=O)N5[C@@H]4SC(C)(C)[C@@H]5C(=O)[O-])c(O)c(O)c3C(C)C)C2=O)C(=O)c2c(/C=N/[C@@H]3C(=O)N4[C@@H]3SC(C)(C)[C@@H]4C(=O)[O-])c(O)c(O)c(C(C)C)c2C1=O.[Na+].[Na+]

Standard InChI:  InChI=1S/C46H46N4O14S2.2Na/c1-13(2)19-25-23(17(31(53)35(19)57)11-47-27-39(59)49-37(43(61)62)45(7,8)65-41(27)49)33(55)21(15(5)29(25)51)22-16(6)30(52)26-20(14(3)4)36(58)32(54)18(24(26)34(22)56)12-48-28-40(60)50-38(44(63)64)46(9,10)66-42(28)50;;/h11-14,27-28,37-38,41-42,53-54,57-58H,1-10H3,(H,61,62)(H,63,64);;/q;2*+1/p-2/b47-11+,48-12+;;/t27-,28-,37+,38+,41-,42-;;/m1../s1

Standard InChI Key:  ZDEKCDBGGFULIS-GLJFYBKGSA-L

Associated Targets(Human)

A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW-620 (52400 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Serum (1292 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BAD Tchem Bcl2-antagonist of cell death (BAD) (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
4T1 (1737 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CT26 (928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Serum (598 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 943.02Molecular Weight (Monoisotopic): 942.2452AlogP: 4.72#Rotatable Bonds: 9
Polar Surface Area: 289.14Molecular Species: ACIDHBA: 16HBD: 6
#RO5 Violations: 3HBA (Lipinski): 18HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 2.64CX Basic pKa: 1.67CX LogP: 4.21CX LogD: -4.01
Aromatic Rings: 2Heavy Atoms: 66QED Weighted: 0.11Np Likeness Score: 0.58

References

1. Yan F, Cao XX, Jiang HX, Zhao XL, Wang JY, Lin YH, Liu QL, Zhang C, Jiang B, Guo F..  (2010)  A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancer.,  53  (15): [PMID:20684596] [10.1021/jm1001698]

Source